Matrine can effectively inhibit the growth of glioblastoma multiforme (GBM) cells in vitro by inducing cell senescence, and downregulate the expression of insulin-like growth factor (IGF1), PI3K, and p-AKT. This evidence concerns the gene IGF1 and glioblastoma.